FdaApplication
NDA 022249
Identifiers
- fda_app_no: NDA022249
Properties
| Property | Value |
|---|---|
| applicant_name | CEPHALON INC |
| application_type | NDA |
| approval_date | 2008-03-20 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TREANDA | BENDAMUSTINE HYDROCHLORIDE | 180MG/2ML (90MG/ML) | SOLUTION;INTRAVENOUS |
| TREANDA | BENDAMUSTINE HYDROCHLORIDE | 100MG/VIAL | POWDER;INTRAVENOUS |
| TREANDA | BENDAMUSTINE HYDROCHLORIDE | 25MG/VIAL | POWDER;INTRAVENOUS |
| TREANDA | BENDAMUSTINE HYDROCHLORIDE | 45MG/0.5ML (90MG/ML) | SOLUTION;INTRAVENOUS |
4 products